These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 8701753)

  • 1. Pharmacokinetics of ceftizoxime in renal failure patients without dialysis.
    Li P; Cai Q; Gao S; Liu GL; Cui RL; Yang XY
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):402-4. PubMed ID: 8701753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Absorption of ceftizoxime from peritoneal dialysate and its pharmacokinetics in chronic kidney failure patients].
    Gao S; Li P; Liu GL; Wang SX; Chui RL; Yang JP
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):377-80. PubMed ID: 1456067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition kinetics of dibekacin in patients with renal failure and in patients undergoing hemodialysis.
    Arancibia A; Baillarie D; Bravo M; Chávez J
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):623-7. PubMed ID: 8688988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of iopamidol in adults with renal failure.
    Corradi A; Menta R; Cambi V; Maccarini P; Cerutti R
    Arzneimittelforschung; 1990 Jul; 40(7):830-2. PubMed ID: 2222559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function.
    Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):25-32. PubMed ID: 12111108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
    Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis.
    Eriksson T; Höglund P; Turesson I; Waage A; Don BR; Vu J; Scheffler M; Kaysen GA
    J Pharm Pharmacol; 2003 Dec; 55(12):1701-6. PubMed ID: 14738599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis.
    Tomino Y; Fukui M; Hamada C; Inoue S; Osada S
    Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal function.
    Neuhauser MM; McKinnon PS; Hershberger E; Rybak MJ
    Pharmacotherapy; 2000 May; 20(5):554-61. PubMed ID: 10809342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure.
    Barré J; Ledudal P; Oosterhuis B; Brakenhoff JP; Wilkens G; Sollie FA; Tran D
    Biopharm Drug Dispos; 2003 May; 24(4):159-64. PubMed ID: 12698499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study and clinical evaluation of cefpodoxime proxetil in the elderly with impaired renal function.
    Ishioka T
    J Chemother; 1995 Nov; 7 Suppl 4():122-3. PubMed ID: 8904130
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.
    Tricot G; Alberts DS; Johnson C; Roe DJ; Dorr RT; Bracy D; Vesole DH; Jagannath S; Meyers R; Barlogie B
    Clin Cancer Res; 1996 Jun; 2(6):947-52. PubMed ID: 9816255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacokinetic trial of intravenous injection of recombinant human lymphotoxin-alpha derivative].
    Li S; Wang FH; Liao H; Li YH; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Dec; 25(12):1524-8. PubMed ID: 17166379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.